Warning: The NCBI web site requires JavaScript to function. more...
Matrix metalloproteinases in arthritic disease.
Murphy G, Knäuper V, Atkinson S, Butler G, English W, Hutton M, Stracke J, Clark I.
Arthritis Res. 2002;4 Suppl 3:S39-49. Epub 2002 May 9. Review.
Related citations
Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?
Murphy G, Nagase H.
Nat Clin Pract Rheumatol. 2008 Mar;4(3):128-35. Review.
The effects of 1 alpha,25-dihydroxyvitamin D(3) on matrix metalloproteinase and prostaglandin E(2) production by cells of the rheumatoid lesion.
Tetlow LC, Woolley DE.
Arthritis Res. 1999;1(1):63-70. Epub 1999 Oct 14.
Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP).
Stracke JO, Fosang AJ, Last K, Mercuri FA, Pendás AM, Llano E, Perris R, Di Cesare PE, Murphy G, Knäuper V.
FEBS Lett. 2000 Jul 28;478(1-2):52-6.
Matrix metalloproteinases: role in arthritis.
Burrage PS, Mix KS, Brinckerhoff CE.
Front Biosci. 2006 Jan 1;11:529-43. Review.
Metalloproteases and inhibitors in arthritic diseases.
Martel-Pelletier J, Welsch DJ, Pelletier JP.
Best Pract Res Clin Rheumatol. 2001 Dec;15(5):805-29. Review.
Progress in matrix metalloproteinase research.
Mol Aspects Med. 2008 Oct;29(5):290-308. Epub 2008 May 24. Review.
Biology of metalloproteinases.
Amălinei C, Căruntu ID, Bălan RA.
Rom J Morphol Embryol. 2007;48(4):323-34. Review.
Structural basis of matrix metalloproteinase function.
Bode W.
Biochem Soc Symp. 2003;(70):1-14. Review.
Using inhibitors of metalloproteinases to treat arthritis. Easier said than done?
Vincenti MP, Clark IM, Brinckerhoff CE.
Arthritis Rheum. 1994 Aug;37(8):1115-26. Review.
Matrix metalloproteinases (MMPs) in health and disease: an overview.
Malemud CJ.
Front Biosci. 2006 May 1;11:1696-701. Review.
The clinical potential of matrix metalloproteinase inhibitors in the rheumatic disorders.
Elliott S, Cawston T.
Drugs Aging. 2001;18(2):87-99. Review.
Aggrecanases and cartilage matrix degradation.
Nagase H, Kashiwagi M.
Arthritis Res Ther. 2003;5(2):94-103. Epub 2003 Feb 14. Review.
The design, structure, and therapeutic application of matrix metalloproteinase inhibitors.
Skiles JW, Gonnella NC, Jeng AY.
Curr Med Chem. 2001 Mar;8(4):425-74. Review.
Structural studies of matrix metalloproteinases.
Borkakoti N.
J Mol Med (Berl). 2000;78(5):261-8. Review.
Fell-Muir Lecture: Metalloproteinases: from demolition squad to master regulators.
Murphy G.
Int J Exp Pathol. 2010 Aug;91(4):303-13.
ADAMTS proteinases: a multi-domain, multi-functional family with roles in extracellular matrix turnover and arthritis.
Jones GC, Riley GP.
Arthritis Res Ther. 2005;7(4):160-9. Epub 2005 Jun 21. Review.
Metalloproteinase inhibitors: biological actions and therapeutic opportunities.
Baker AH, Edwards DR, Murphy G.
J Cell Sci. 2002 Oct 1;115(Pt 19):3719-27. Review.
What are the roles of metalloproteinases in cartilage and bone damage?
Murphy G, Lee MH.
Ann Rheum Dis. 2005 Nov;64 Suppl 4:iv44-7. Review.
Matrix metalloproteinase knockout studies and the potential use of matrix metalloproteinase inhibitors in the rheumatic diseases.
Milner JM, Cawston TE.
Curr Drug Targets Inflamm Allergy. 2005 Jun;4(3):363-75. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on